# US 2022/0031724 A1 · Injectable antibiotic formulations and use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0031724 A1
- Document ID: US20220031724A1
- Status: Published application
- Kind: A1
- Application number: 17/197,838
- Filed: 2021-03-10
- Published: 2022-02-03
- Earliest claimed: 2015-06-10
- Assignees: Piedmont Animal Health Inc.
- Applicants: Piedmont Animal Health Inc.
- Inventors: Neil E. Paulsen; Gail L. Dempsey; Michael S. Daniel; Tiffany G. Tomlinson; Douglas I. Hepler; Raymond Petzold
- Web page: https://patentgrep.com/patent/US20220031724A1

## CPC

- A61K 31/7052: having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K 9/0019: {Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner (non-active ingredients are additionally classified in A61K47/00)}
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61K 47/14: Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A61K 47/44: Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin (synthetic glycerides, e.g. medium-chain triglycerides, A61K47/14)
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

Provided herein are pharmaceutically acceptable compositions containing macrolide antibiotics, in particular azithromycin. In particular, compositions containing azithromycin with low toxicity, especially for administration to felines, are provided herein.

## Claims

### Claim 1

A composition, comprising:
(i) a hydrated macrolide;
(ii) at least one suitable solvent; and
(iii) an excipient.

### Claim 2 (depends on 1)

The composition of claim 1, wherein the solvent is triacetin.

### Claim 3 (depends on 1)

The composition of claim 1, wherein the macrolide is azithromycin.

### Claim 4 (depends on 1)

The composition of claim 1, wherein the solvent is present in an amount of about 38.0% w/w.

### Claim 5 (depends on 1)

The composition of claim 1, further comprising a surfactant.

### Claim 6 (depends on 5)

The composition of claim 5, wherein the surfactant is castor oil.

### Claim 7 (depends on 5)

The composition of claim 5, wherein the castor oil comprises kalliphor HS15.

### Claim 8 (depends on 1)

The composition of claim 1, wherein the solvent is caprylic or caprylic/capric triglycerides.

### Claim 9 (depends on 8)

The composition of claim 8, wherein the solvent is present in an amount of about 54.0% w/w.

### Claim 10 (depends on 1)

The composition of claim 1, wherein azithromycin is present in an amount of about 7.0% w/w.

### Claim 11 (depends on 1)

The composition of claim 1, wherein the solvent is triacetin and caprylic, caprylic or capric triglycerides.

### Claim 12 (depends on 8)

The composition of claim 8, wherein the triglyceride is a C8 triglyceride.

### Claim 13 (depends on 11)

The composition of claim 11, wherein the triglyceride is a C8 triglyceride.

### Claim 14 (depends on 1)

The composition of claim 1, wherein the composition is formulated for injection.

### Claim 15 (depends on 1)

A method of treating an infection in a subject weighing less than about 100 pounds, comprising administering an effective amount of a composition of claim 1.

### Claim 16 (depends on 1, 15)

The method of claim 15, further comprising administering an additional antibiotic in combination with the composition of claim 1.

### Claim 17 (depends on 15)

The method of claim 15, wherein the subject is a feline.

### Claim 18 (depends on 15)

The method of claim 15, wherein the composition is administered by injection.

### Claim 19

A composition formulated for injection, comprising about 54.0% w/w caprylic triglycerides; about 38.0% w/w triacetin; KALLIPHOR™ HS15; and about 7.0% w/w azithromycin DH.
